Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - pimobendan - capsule, hard - 5 milligram(s) - pimobendan - dogs - cardiovascular

New Zealand - English - Ministry for Primary Industries

boehringer ingelheim animal health new zealand limited - pimobendan - pimobendan 18.6 g/kg - cardiovascular agent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - pimobendan - oral capsule - pimobendan pyridazinone active 5.0 mg/cp - cardiovascular system - dog | bitch | castrate | puppy - congestive heart failure | dilated cardiomyopathy | mitral and/or tricuspid regur | valvular insufficiency

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim ltd - pimobendan - capsules hard - 5 milligram - pimobendane - canine - cardiovascular

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - pimobendan - oral capsule - pimobendan pyridazinone active 1.25 mg/cp - cardiovascular system - dog | bitch | castrate | puppy - congestive heart failure | dilated cardiomyopathy | mitral and/or tricuspid regur | valvular insufficiency

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - pimobendan - oral capsule - pimobendan pyridazinone active 2.5 mg/cp - cardiovascular system - dog | bitch | castrate | puppy - congestive heart failure | dilated cardiomyopathy | mitral and/or tricuspid regur | valvular insufficiency

New Zealand - English - Ministry for Primary Industries

boehringer ingelheim animal health new zealand limited - pimobendan - pimobendan 12.5 g/kg - cardiovascular agent

New Zealand - English - Ministry for Primary Industries

boehringer ingelheim animal health new zealand limited - pimobendan - pimobendan 12.5 g/kg - cardiovascular agent

United States - English - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - pimobendan (unii: 34ap3bbp9t) (pimobendan - unii:34ap3bbp9t) - 1. for the treatment of congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency. it is recommended that the diagnosis of congestive heart failure be confirmed by radiographs or diuretic responsiveness. treatment should be initiated only in symptomatic cases which will benefit from increased myocardial contractility (positive inotropy). 2. to delay the time of onset of congestive heart failure or sudden death in doberman pinscher dogs with clinically asymptomatic dilated cardiomyopathy. clinically asymptomatic dilated cardiomyopathy is characterized by an increase in left ventricular end-systolic and end-diastolic diameter and should be diagnosed by means of a comprehensive cardiac examination (including echocardiographic examination and possibly holter monitoring). vetmedin® capsules should not be used in cases of hypertrophic cardiomyopathies or clinical conditions where an augmentation of cardiac output is not possible for functional or anatomical reasons (e.g. aortic ste

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim ltd - pimobendan - capsule, hard - 5 milligram(s) - pimobendan - dogs - cardiovascular